Enhancing the QUAlity and Transparency Of health Research

EQUATOR resources in German | Portuguese | Spanish

Blog Archives

02/08/2019 CONSORT 2010 statement: extension to randomised crossover trials 16/05/2017 CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials 15/01/2017 The REFLECT statement: methods and processes of creating reporting guidelines for randomized controlled trials for livestock and food safety by modifying the CONSORT statement 10/08/2015 A call for transparent reporting to optimize the predictive value of preclinical research 30/09/2013 Better reporting of harms in randomized trials: an extension of the CONSORT Statement 14/08/2013 Electrodermal activity at acupoints: literature review and recommendations for reporting clinical trials 08/08/2013 Guidelines for the reporting of renal artery revascularization in clinical trials 07/08/2013 Standardized definitions and clinical endpoints in carotid artery and supra-aortic trunk revascularization trials 17/07/2013 Standardized reporting of bleeding complications for clinical investigations in acute coronary syndromes: a proposal from the academic bleeding consensus (ABC) multidisciplinary working group 15/07/2013 A reporting guideline for clinical platelet transfusion studies from the BEST Collaborative

Blog archives

Latest guest blogger

  • Why did we develop TIDieR-Placebo?

    The TIDieR reporting guideline helps authors fully report their interventions, so that they can be used by others. However, TIDieR only explicitly covers active interventions, not placebo controls. The developers of the new TIDieR-Placebo extension explain why it is needed Read More